Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6686850 | 1.00 | LMNA (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL1978843 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL10353701 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL3326274 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL7715586 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL9511157 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL10353311 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL130784 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL1978841 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA | |
| SCHEMBL3326271 | 0.98 | CNR1 (0.49) | LMNACNR1DAGLAGAANAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0342056-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1994-08-17 | — | — | EP | claimed |
| EP-0342054-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1993-11-03 | — | — | EP | claimed |
| EP-0342056-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-11-15 | — | — | EP | claimed |
| EP-0342054-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-11-15 | — | — | EP | claimed |
| WO-2004032972-A1 | AN ORAL FORMULATION OF METHYLGLYOXAL AND ITS IMINO ACID CONJUGATES FOR HUMAN USE | DABUR RESEARCH FOUNDATION (IN) | 2004-04-22 | — | — | WO | disclosed |
| WO-2003003978-A2 | AN ORAL FORMULATION OF METHYLGLYOXAL AND ITS IMINO ACID CONJUGATES FOR HUMAN USE | DABUR RESEARCH FOUNDATION (IN) | 2003-01-16 | — | — | WO | disclosed |
| WO-2003004469-A1 | ANTICANCER ACTIVITY OF IMINO ACID CONJUGATES OF METHYLGLYOXAL | DABUR RESEARCH FOUNDATION (IN) | 2003-01-16 | — | — | WO | disclosed |
| US-5972237-A | USED AS COLD BLEACH ACTIVATORS OR OPTICAL BRIGHTENERS IN DETERGENTS, CLEANERS AND BLEACHES AND IN DISINFECTANTS | BASF AKTIENGESELLSCHAFT (DE) | 1999-10-26 | — | — | US | disclosed |
| EP-0397519-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1994-11-09 | — | — | EP | disclosed |
| US-5158955-A | Hair growth stimulant | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1992-10-27 | — | — | US | disclosed |
| EP-0397519-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1990-11-14 | — | — | EP | disclosed |